Home > Insider Trading > Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc. (SUPN)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
31 - 40
Next >>

Here's What Hedge Funds Think About Supernus Pharmaceuticals Inc (SUPN)

It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not...

Keep Reading →

May 1st, 2019 - Hedge Funds News

Hedge Funds Aren't Crazy About Supernus Pharmaceuticals Inc (SUPN) Anymore

"Market volatility has picked up again over the past few weeks. Headlines highlight risks regarding interest rates, the Fed, China, house prices, auto sales, trade wars, and more. Uncertainty abounds.

Keep Reading →

December 20th, 2018 - Hedge Funds News

Hedge Funds Are Crazy About Supernus Pharmaceuticals Inc (SUPN)

Looking for high-potential stocks? Just follow the big players within the hedge fund industry.

Keep Reading →

December 2nd, 2016 - Hedge Funds News

Here's Why Supernus Pharmaceuticals, Rent-A-Center and Three Other Stocks are Down Today

Stocks are extending losses on Tuesday, mainly due to healthcare sector, which is down over 2%, and slipping crude prices.

Keep Reading →

October 11th, 2016 - Market Movers News

Should You Buy Supernus Pharmaceuticals Inc (SUPN)?

Looking for high-potential stocks? Just follow the big players within the hedge fund industry! This is not an ad, but let’s take a brief look at what statistics has to say about hedge funds’ stock...

Keep Reading →

November 21st, 2015 - Hedge Funds News

Tang Capital Management Discloses Moves into La Jolla Pharmaceutical Company (LJPCD), Vanda Pharmaceuticals Inc. (VNDA), Mirati Therapeutics Inc. (MRTX) & Others

Tang Capital Management, led by Kevin C. Tang, revealed in a filing several moves that have impacted its equity portfolio.

Keep Reading →

January 16th, 2014 - Hedge Funds News

Philip Hempleman, Ardsley Partners Initiate Position in Supernus Pharmaceuticals Inc (SUPN)

Philip Hempleman has become a fan of Supernus Pharmaceuticals Inc (NASDAQ:SUPN).

Keep Reading →

December 13th, 2013 - Hedge Funds News

Orchard Hill Reports a 10% Stake in Supernus Pharmaceuticals

Orchard Hill, Supernus Pharmaceuticals: Earlier this year, Orchard Hill Capital Management purchased a position in Supernus Pharmaceuticals Inc (NASDAQ:SUPN) which contained 3.5 million shares, a new...

Keep Reading →

October 23rd, 2013 - Hedge Funds News

Hi-Tech Pharmacal Co. (HITK): Hedge Funds Aren't Crazy About It, Insider Sentiment Unchanged

To the average investor, there are tons of gauges investors can use to monitor stocks. A duo of the best are hedge fund and insider trading activity.

Keep Reading →

September 3rd, 2013 - News

Big Movers News: Biodel Inc (BIOD)'s Big News, Supernus Pharmaceuticals Inc (SUPN)'s Spike

Biodel had its price target increased by JMP Securities from $6.00 to $9.00 in a research report sent to investors on Thursday morning, StockRatingsNetwork.com reports.

Keep Reading →

August 19th, 2013 - News